Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications patient preferences her2 targeted treatment advanced metastatic breast cancer united
… the use of cytotoxic chemotherapy in patients with HR+/HER2– metastatic breast cancer. The study focused on Medicare … breast cancer. The research also identified several patient-level factors and social determinants of health as … patients with HR+/HER2– metastatic breast cancer. Links to publications: Goyal RK, Chen H, Abughosh SM, Holmes HM, …
… and aromatase inhibitor therapy among patients with HR+/HER2− advanced breast cancer in Europe. Oikonomidou O, Galve-Calvo … Real-world clinical outcomes among patients (pts) with metastatic/advanced triple-negative breast cancer (mTNBC) in …
… may be methodologically simple, or it may require advanced epidemiological methods. Either way, we have you … competencies. Seminars used to enhance competence in advanced methods as a preparation for the development of …
… the 2022 San Antonio Breast Cancer Symposium. Real-world treatment patterns and clinical outcomes in patients treated … with Eribulin after prior PI3K inhibitor therapy for metastatic breast cancer. Goyal RK, Zhang J, Davis KL, Kaufman PA. Poster P1-03-03 Treatment - Advanced Disease Treatment: Advanced Chemotherapy Poster …
… Benefit-Risk Preferences Benefit-risk preference studies are a specific … and other decision-makers perceive the benefits of your treatment features and their tolerance for possible risks. … the relative importance of benefits and risks and a patient’s maximum acceptable risk (MAR). If the actual risk …
… to get what is important to them? For example, if your patient has to choose between a highly effective drug with a … you to fully understand the potential and positioning of a treatment in the market. Preference studies can be used to … you understand your patients’ (or other stakeholders’) preferences and predict how they value different treatment …
… Patient-Centered Outcomes Assessment Whether your goal is to … product claims, facilitate market access, or improve patient-clinician communication, our Patient-Centered … of their mastery of essential principles as well as advanced techniques, our experts are often asked to teach …
… experts will be presented at the ESMO Congress 2023. Breast cancer specific survival (BCSS) in HR+/HER2- metastatic breast cancer (mBC) from 2010 to 2019. Brufsky A, …
… not wholly consistent. Identifying the RET gene can impact patient treatment as well as help patients and their families … the recommended genetic testing in this population. Publications: Bhandari NR, Hess LM, Parikh RC, Sireci AN, …
… Analysis of Heterogeneity of Treatment Effects for Patient-Centered Outcomes Let us help … geography, standards of care, or even expectations and preferences—for which your drug is highly effective. And the …